iBio(IBIO) - 2022 Q2 - Quarterly Report

For the transition period from ___ to ___ Commission file number 001-35023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 iBio, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...